Marshall Wace’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-64,388
| Closed | -$93.4K | – | 2478 |
|
|
2023
Q1 | $93.4K | Buy |
64,388
+13,471
| +26% | +$19.5K | ﹤0.01% | 2007 |
|
|
2022
Q4 | $88.1K | Sell |
50,917
-135,653
| -73% | -$235K | ﹤0.01% | 2205 |
|
|
2022
Q3 | $374K | Buy |
186,570
+150,201
| +413% | +$301K | ﹤0.01% | 2144 |
|
|
2022
Q2 | $27K | Buy |
36,369
+10,342
| +40% | +$7.68K | ﹤0.01% | 2615 |
|
|
2022
Q1 | $227K | Buy |
+26,027
| New | +$227K | ﹤0.01% | 2351 |
|
|
2019
Q3 | – | Sell |
-17,699
| Closed | -$204K | – | 1866 |
|
|
2019
Q2 | $204K | Buy |
17,699
+14,625
| +476% | +$169K | ﹤0.01% | 1211 |
|
|
2019
Q1 | $39K | Buy |
+3,074
| New | +$39K | ﹤0.01% | 1551 |
|